Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project.

Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, Hopman W, Clark DS, Mauer AC, Bowman M, Riddel J, Christopherson PA, Montgomery RR; Zimmerman Program Investigators, Rand ML, Coller B, James PD.

Haemophilia. 2014 Nov;20(6):831-5. doi: 10.1111/hae.12503. Epub 2014 Sep 6.

2.

Diagnostic Prediction of Von Willebrand Disease using Multiple Bleeding Phenomics Datasets.

Mollah SA, James PB, Grabell J, Barbour EM, Coller B.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:184. eCollection 2013.

PMID:
24303262
3.

Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS).

CTSA Principal Investigators, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, Califf R, Stephens D, Mellman T, Verbalis J, Nadler L, Shekhar A, Ford D, Rizza R, Shaker R, Brady K, Murphy B, Cronstein B, Hochman J, Greenland P, Orwoll E, Sinoway L, Greenberg H, Jackson R, Coller B, Topol E, Guay-Woodford L, Runge M, Clark R, McClain D, Selker H, Lowery C, Dubinett S, Berglund L, Cooper D, Firestein G, Johnston SC, Solway J, Heubi J, Sokol R, Nelson D, Tobacman L, Rosenthal G, Aaronson L, Barohn R, Kern P, Sullivan J, Shanley T, Blazar B, Larson R, FitzGerald G, Reis S, Pearson T, Buchanan T, McPherson D, Brasier A, Toto R, Disis M, Drezner M, Bernard G, Clore J, Evanoff B, Imperato-McGinley J, Sherwin R, Pulley J.

Clin Transl Sci. 2012 Apr;5(2):121-9. doi: 10.1111/j.1752-8062.2012.00401.x. Epub 2012 Mar 27.

4.

Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease.

Blumenfeld JD, Tepler J, Mauer A, Coller B, Bichet DG, Smith B.

Blood. 2011 Jul 14;118(2):474-6. doi: 10.1182/blood-2011-04-347328. No abstract available.

5.

Inhibitors of Platelet Integrin αllbβ3.

McCoy J, Shen M, Huang W, Coller B, Thomas CJ.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2010 Mar 27 [updated 2011 Mar 3].

6.

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group.

J Thromb Haemost. 2010 Sep;8(9):2063-5. doi: 10.1111/j.1538-7836.2010.03975.x. No abstract available.

7.
8.

Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL.

Am J Respir Crit Care Med. 2003 Apr 1;167(7):1027-35. Review.

PMID:
12663342
9.

Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells.

Rastegar R, Harnick DJ, Weidemann P, Fuster V, Coller B, Badimon JJ, Chesebro J, Goldman ME.

J Am Coll Cardiol. 2003 Feb 19;41(4):603-10.

10.

Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.

Shpilberg O, Rabi I, Schiller K, Walden R, Harats D, Tyrrell KS, Coller B, Seligsohn U.

Circulation. 2002 Mar 5;105(9):1044-8.

PMID:
11877352
11.

Outpatient treatment of deep venous thrombosis in diverse inner-city patients.

Dunn AS, Schechter C, Gotlin A, Vomvolakis D, Jacobs E, Sacks HS, Coller B.

Am J Med. 2001 Apr 15;110(6):458-62.

PMID:
11331057
12.

Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G.

Chest. 2001 Jan;119(1 Suppl):39S-63S. Review. No abstract available.

PMID:
11157642
13.

Outpatient treatment of deep vein thrombosis: translating clinical trials into practice.

Dunn AS, Coller B.

Am J Med. 1999 Jun;106(6):660-9. Review.

PMID:
10378625
14.

Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.

Shi ZT, Afzal V, Coller B, Patel D, Chasis JA, Parra M, Lee G, Paszty C, Stevens M, Walensky L, Peters LL, Mohandas N, Rubin E, Conboy JG.

J Clin Invest. 1999 Feb;103(3):331-40.

15.

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

Patrono C, Coller B, Dalen JE, Fuster V, Gent M, Harker LA, Hirsh J, Roth G.

Chest. 1998 Nov;114(5 Suppl):470S-488S. Review. No abstract available.

PMID:
9822058
16.

Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

Jin Y, Dietz HC, Montgomery RA, Bell WR, McIntosh I, Coller B, Bray PF.

J Clin Invest. 1996 Oct 15;98(8):1745-54.

17.

Vertical tripod fixation (VTF) simplifies transscleral approaches.

Berger RR, Kenyers AM, Van Coller B, Pretorius CF.

Ophthalmic Surg. 1995 Jul-Aug;26(4):367-71.

PMID:
8532294
18.

[Rapid detection of platelet glycoprotein IIb, IIIA gene variety by single strand conformation polymorphism analysis].

Chen F, Coller B, French D.

Zhonghua Yi Xue Za Zhi. 1995 Jun;75(6):341-3, 382. Chinese.

PMID:
7553144
19.

Procedures involving star-shaped capsulectomy for managing congenital cataracts in developing nations.

Berger RR, Kenyeres AM, Van Coller B, Pretorius CF.

Ophthalmic Surg. 1994 Sep-Oct;25(9):649-53.

PMID:
7831016
20.

[Diffuse corneal pigmentation--a new sign in neurofibromatosis].

Berger RR, Kenyeres AM, Van Coller B, Pretorius CF.

Harefuah. 1994 May 1;126(9):514-5, 563. Hebrew.

PMID:
8034266

Supplemental Content

Loading ...
Support Center